2015
DOI: 10.1016/j.ab.2014.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Development of surface plasmon resonance imaging biosensors for detection of ubiquitin carboxyl-terminal hydrolase L1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
35
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 35 publications
(35 citation statements)
references
References 32 publications
0
35
0
Order By: Relevance
“…Activation of the antibody was performed by adding the mixture of NHS and EDC (1 : 1) in a carbonate buffer solution (pH 8Á5) into the antibody solution and with vigorous stirring for 5 min at the room temperature. Three ml of this solution was placed on the active places with the amine-modified surface, and incubated at for 1 h' [32].…”
Section: Chip Preparationmentioning
confidence: 99%
See 3 more Smart Citations
“…Activation of the antibody was performed by adding the mixture of NHS and EDC (1 : 1) in a carbonate buffer solution (pH 8Á5) into the antibody solution and with vigorous stirring for 5 min at the room temperature. Three ml of this solution was placed on the active places with the amine-modified surface, and incubated at for 1 h' [32].…”
Section: Chip Preparationmentioning
confidence: 99%
“…According to Sankiewicz et al, 'This is a label-free, surfacesensitive spectroscopic technique used to examine the interaction between biomolecules' [30][31][32]. SPRI is based on detection of changes in the refractive index within a short distance from the surface of a thin metal film caused by molecules bound to the metal surface [32]. The researched substance is captured from the solution by the antibody or inhibitor [30][31][32].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…SPR sensing has been significantly developed in recent years to quantify biomarkers in complex matrixes, such as serum (Choi et al, 2010;Su et al, 2008 andLadd et al, 2009), plasma (Teramura et al, 2007), saliva (Yang et al, 2005) and cell lysate (Kyo et al, 2005). SPR biosensors have been shown to be suited for the detection of several cancer biomarkers (Sankiewicz et al, 2015) in solubilized samples, such as oropharyngeal squamous cell carcinoma (Liu et al, 2012), prostate cancer (Choi et al, 2010), colorectal, gastric, and pancreatic cancer (Su et al, 2008), intestinal cancer (Ladd et al, 2009), liver cancer (Teramura et al, 2007) and ovarian cancer (Liu et al, 2012) among others. However, serum and cell lysate screening on SPRi provide real time detection results in less time with low human error, but due to their protein and lipid rich matrix respectively, they expected to significantly foul on sensor surface.…”
Section: Introductionmentioning
confidence: 99%